Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Analyzing Non-Inspected Foreign Firms Which Are Named in NDAs

Executive Summary

FDA's next step in analyzing data from the Operational and Administrative System for Import Support will be to identify non-inspected foreign drug firms referenced in approved human or animal drug applications.

You may also be interested in...



Rx Import Bill Undercuts FDA Approach To Quality Control, Lilly Exec Testifies

FDA's process focus in GMP regulation illustrates the importance of manufacturer control over importation into the U.S., Lilly Europe/North America Area Quality Control Leader Nikki Mehringer told the House Commerce/Oversight Subcommittee Oct. 3.

Rx Import Bill Undercuts FDA Approach To Quality Control, Lilly Exec Testifies

FDA's process focus in GMP regulation illustrates the importance of manufacturer control over importation into the U.S., Lilly Europe/North America Area Quality Control Leader Nikki Mehringer told the House Commerce/Oversight Subcommittee Oct. 3.

Bulk Drug Import Quality Reports May Be Required From U.S. Firms

Pharmaceutical manufacturers may be required to notify FDA when they receive bulk drugs of poor quality, FDA Associate Commissioner for Regulatory Affairs Dennis Baker told a House subcommittee hearing June 8.

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel